Array Biopharmaceuticals' intraday fluctuations quickly pulled up 5.01% to $6.71

Source: Market Information

At 01:08 on January 24, 2025, Beijing time, Array Biopharmaceuticals (ARRY.us) stock fluctuated, with the share price rising rapidly by 5.01%. As of press time, the stock was trading at $6.71 per share, with a trading volume of 1.47972 million shares, a turnover rate of 0.97%, and an amplitude of 6.89%.

The latest financial report data shows that the stock achieved operating income of US$231 million, net profit of -US$141 million, earnings per share of -US$1.02, gross profit of US$69.44 million, and price-earnings ratio of -6.83 times.

In terms of institutional ratings, among all 25 institutions participating in the ratings, 52% of brokerages gave buy recommendations, 44% of brokerages gave hold recommendations, and 4% of brokerages gave sell recommendations.

In the solar industry where Array Biopharmaceuticals' stock is located, the overall decline was 1.33%. Among its related stocks, Solarmax Technology Inc., Complete Solaria Inc C/Wts 31/07/2028 (To Pur Com), and Array Biopharmaceuticals had large increases, while Sunnova Energy International Inc., Solaredge Technologies, Inc., and Beam Global were relatively active, with turnover rates of 6.30%, 3.71%, and 3.23%, respectively. Related stocks with large amplitudes included Complete Solaria Inc C/Wts 31/07/2028 (To Pur Com), Zeo Energy Corporation, and Solarmax Technology Inc., with amplitudes of 36.28%, 20.24%, and 12.80%, respectively.

Array Biopharmaceuticals Company Profile: Array Technologies Inc is a manufacturer of ground-mounted systems used in solar projects. The company's product is an integrated system of steel brackets, motors, gearboxes and electronic controllers, called single-axis trackers, which can move solar panels throughout the day to maintain the best direction toward the sun, thereby increasing their energy production. Its operations are spread across the United States, Australia, Spain, Brazil and other parts of the world, with the United States generating the majority of its revenue.